Could slow breathing help PAH patients breathe easier?
NCT ID NCT07232368
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether slow-paced breathing at home can help people with pulmonary arterial hypertension (PAH) manage symptoms like shortness of breath, fatigue, and poor sleep. Forty-two adults with stable PAH took part, with one group adding slow breathing exercises to their usual care for 12 weeks. Researchers measured changes in breathing, walking ability, blood markers, and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- slow-paced breathing
- What this could lead to
- If it works, this could offer a simple, drug-free way to help manage breathlessness, fatigue, and sleep quality in people with pulmonary arterial hypertension.
- What could go wrong
- This is a small, completed study with only 42 participants, so results may not apply to everyone. The breathing technique may not work for all patients or provide lasting benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ege Üniversitesi
Izmir, Bornova, 35100, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New hope for PAH patients: Extended-Release tacrolimus enters phase 3 trial
- New ultrasound score may sharpen risk prediction for PAH patients
- One pill to rule them all? new combo therapy for PAH shows promise
- New quiz aims to boost lung disease care
- Study aims to uncover why a deadly lung disease is often diagnosed too late
- PAH drug switch under the microscope: will patients benefit?